Literature DB >> 18715810

Staging and prognosis in head and neck cancer.

Marc P van der Schroeff1, Robert J Baatenburg de Jong.   

Abstract

Head and neck malignant tumors are classified according to the TNM staging system. The TNM system is a universally accepted, widely used, staging method. Its goals are to help clinicians and researchers to choose from treatment options, to give patients an estimate of their prognosis and to compare results of treatment. In this paper we discuss the history and daily usage of the TNM system and some pros and cons. In the field of prognostic estimations, particularly for the individual patient, the TNM system could be upgraded with other prognostic indicators. We discuss insights into enhanced usage of the TNM system and the possibilities of comprehensive and dynamic staging models.

Entities:  

Mesh:

Year:  2008        PMID: 18715810     DOI: 10.1016/j.oraloncology.2008.05.022

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  21 in total

1.  Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.

Authors:  Waseem Jerjes; Tahwinder Upile; Aviva Petrie; Andrew Riskalla; Zaid Hamdoon; Michael Vourvachis; Kostas Karavidas; Amrita Jay; Ann Sandison; Gareth J Thomas; Nicholas Kalavrezos; Colin Hopper
Journal:  Head Neck Oncol       Date:  2010-04-20

2.  Analysis of ECOG performance status in head and neck squamous cell carcinoma patients: association with sociodemographical and clinical factors, and overall survival.

Authors:  Gefter Thiago Batista Corrêa; Gabriela Alencar Bandeira; Bruna Gonçalves Cavalcanti; Francis Balduíno Guimarães Santos; João Felício Rodrigues Rodrigues Neto; André Luiz Sena Guimarães; Desirée Sant'Ana Haikal; Alfredo Maurício Batista De Paula
Journal:  Support Care Cancer       Date:  2012-11       Impact factor: 3.603

Review 3.  Positron Emission Tomography (PET) in Oncology.

Authors:  Andrea Gallamini; Colette Zwarthoed; Anna Borra
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

4.  Factors Influencing Early Detection of Oral Cancer by Primary Health-Care Professionals.

Authors:  Y Hassona; C Scully; A Shahin; W Maayta; F Sawair
Journal:  J Cancer Educ       Date:  2016-06       Impact factor: 2.037

5.  A prospective study of prognostic factors for recurrence in early oral tongue cancer.

Authors:  Prashant Sharma; S V Shah; Charu Taneja; Ashok M Patel; Mahesh D Patel
Journal:  J Clin Diagn Res       Date:  2013-11-10

Review 6.  Anti-epidermal growth factor receptor therapy in head and neck squamous cell carcinoma: focus on potential molecular mechanisms of drug resistance.

Authors:  Carolien Boeckx; Marc Baay; An Wouters; Pol Specenier; Jan B Vermorken; Marc Peeters; Filip Lardon
Journal:  Oncologist       Date:  2013-07-02

7.  Influence of tumor volume on survival in patients with oral squamous cell carcinoma.

Authors:  Thomas Mücke; David A Mitchell; Lucas M Ritschl; Andrea Tannapfel; Klaus-Dietrich Wolff; Marco R Kesting; Denys J Loeffelbein; Anastasios Kanatas
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-26       Impact factor: 4.553

8.  Correlations between prognosis and regional biomarker profiles in head and neck squamous cell carcinomas.

Authors:  Gabriella Szentkúti; Kornél Dános; Diána Brauswetter; Gergő Kiszner; Tibor Krenács; László Csákó; Gábor Répássy; László Tamás
Journal:  Pathol Oncol Res       Date:  2014-12-31       Impact factor: 3.201

9.  Modification of staging and treatment of head and neck cancer by FDG-PET/CT prior to radiotherapy.

Authors:  A Abramyuk; S Appold; K Zöphel; M Baumann; N Abolmaali
Journal:  Strahlenther Onkol       Date:  2013-01-19       Impact factor: 3.621

10.  Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.

Authors:  Christophe Van de Wiele; Vibeke Kruse; Peter Smeets; Mike Sathekge; Alex Maes
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.